AJP - GI Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 294: G963-G970, 2008. First published February 7, 2008; doi:10.1152/ajpgi.00562.2007
0193-1857/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/4/G963    most recent
00562.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Page, A. J.
Right arrow Articles by Blackshaw, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Page, A. J.
Right arrow Articles by Blackshaw, L. A.

NEUROREGULATION AND MOTILITY

Opioid modulation of ferret vagal afferent mechanosensitivity

Amanda J. Page,1,2,3 Tracey A. O'Donnell,1 and L. Ashley Blackshaw1,2,3

1Nerve Gut Research Laboratory, Department of Gastroenterology and Hepatology, Hanson Institute, Royal Adelaide Hospital; and 2Discipline of Medicine and 3Discipline of Physiology, School of Molecular and Biomedical Sciences, University of Adelaide, Adelaide, Australia

Submitted 3 December 2007 ; accepted in final form 2 February 2008

Despite universal use of opioids in the clinic to inhibit pain, there is relatively little known of their peripheral actions on sensory nerve endings, where in fact they may be better targeted with more widespread applications. Here we show differential effects of µ-, {kappa}-, and {delta}-opioids on mechanosensitive ferret esophageal vagal afferent endings investigated in vitro. The effects of selective agonists [D-Ala2,N-Me-Phe4,Gly-ol5]-enkephalin (DAMGO), 2-(3, 4-dichlorophenyl)-N-methyl-N-[(1S)-1phenyl-2-(1-pyrrolidinyl) ethyl] acetamide hydrochlorine (ICI 199441), and (+)-4-[({alpha}R)-{alpha}-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC-80), respectively, on mechanosensory stimulus-response functions were quantified. DAMGO (10–7 to 10–5 M) reduced the responses of tension receptors to circumferential tension (1–5 g) by up to 50%, and the responses of mucosal receptors to mucosal stroking (10–1,000 mg von Frey hair) by >50%. DAMGO effects were reversed by naloxone (10–5 M). Tension/mucosal (TM) receptor responses to tension and stroking were unaffected by DAMGO. ICI 199441 (10–6 to 10–5 M) potently inhibited all responses except TM receptor responses to tension, and SNC-80 (10–5 to 10–3 M) had no effect other than a minor inhibition of mucosal receptor responses to intense stimuli at 10–3 M. We conclude that µ- and {kappa}-opioids have potent and selective peripheral effects on esophageal vagal afferents that may have applications in treatment of disorders of visceral sensation.

vagal afferents; neuromodulation; esophagus



Address for reprint requests and other correspondence: A. J. Page, Nerve Gut Research Laboratory, Level 1 Hanson Institute, Frome Rd., Adelaide, SA 5000, Australia (e-mail: amanda.page{at}health.sa.gov.au)




This article has been cited by other articles:


Home page
GutHome page
P A Hughes, S M Brierley, C M Martin, T Liebregts, J Persson, B Adam, G Holtmann, and L A Blackshaw
TRPV1-expressing sensory fibres and IBS: links with immune function
Gut, March 1, 2009; 58(3): 465 - 466.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.